
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10311579
[patent_doc_number] => 20150196581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/600253
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15268
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600253
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/600253 | Compositions for external application, containing adenosylcobalamin for improvement of skin diseases | Jan 19, 2015 | Issued |
Array
(
[id] => 11335534
[patent_doc_number] => 20160361289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 15/113127
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18085
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113127
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/113127 | Treatment of metabolic disorders in canine animals | Jan 19, 2015 | Issued |
Array
(
[id] => 11684067
[patent_doc_number] => 09682099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Compositions and methods for treating joints'
[patent_app_type] => utility
[patent_app_number] => 14/600770
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 15507
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600770
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/600770 | Compositions and methods for treating joints | Jan 19, 2015 | Issued |
Array
(
[id] => 11684933
[patent_doc_number] => 09682969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Phthalazinone compounds and methods for the treatment of cystic fibrosis'
[patent_app_type] => utility
[patent_app_number] => 14/599998
[patent_app_country] => US
[patent_app_date] => 2015-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10855
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14599998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/599998 | Phthalazinone compounds and methods for the treatment of cystic fibrosis | Jan 18, 2015 | Issued |
Array
(
[id] => 10255179
[patent_doc_number] => 20150140176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Carbohydrate Gel'
[patent_app_type] => utility
[patent_app_number] => 14/599197
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5827
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14599197
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/599197 | Carbohydrate Gel | Jan 15, 2015 | Abandoned |
Array
(
[id] => 13263267
[patent_doc_number] => 10143703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Treating ocular neovascularization
[patent_app_type] => utility
[patent_app_number] => 15/108751
[patent_app_country] => US
[patent_app_date] => 2015-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 86
[patent_no_of_words] => 15112
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108751 | Treating ocular neovascularization | Jan 1, 2015 | Issued |
Array
(
[id] => 10311575
[patent_doc_number] => 20150196577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'Compounds, Compositions and Methods for Protecting Brain Health in Neurodegenerative Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/584581
[patent_app_country] => US
[patent_app_date] => 2014-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 28409
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14584581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/584581 | Compounds, compositions and methods for protecting brain health in neurodegenerative disorders | Dec 28, 2014 | Issued |
Array
(
[id] => 10457957
[patent_doc_number] => 20150342973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'ANTIBIOTIC COMPOSITIONS AND RELATED SCREENING METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/578453
[patent_app_country] => US
[patent_app_date] => 2014-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9186
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14578453
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/578453 | ANTIBIOTIC COMPOSITIONS AND RELATED SCREENING METHODS | Dec 20, 2014 | Abandoned |
Array
(
[id] => 11269230
[patent_doc_number] => 20160331777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'USE OF ALGINATE OLIGOMERS AS BLOOD ANTICOAGULANTS'
[patent_app_type] => utility
[patent_app_number] => 15/106196
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16625
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106196
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/106196 | Use of alginate oligomers as blood anticoagulants | Dec 18, 2014 | Issued |
Array
(
[id] => 10220474
[patent_doc_number] => 20150105467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN'
[patent_app_type] => utility
[patent_app_number] => 14/576404
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4354
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576404
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/576404 | FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN | Dec 18, 2014 | Abandoned |
Array
(
[id] => 10279860
[patent_doc_number] => 20150164856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 14/573352
[patent_app_country] => US
[patent_app_date] => 2014-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20112
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14573352
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/573352 | Treatment of metabolic disorders in feline animals | Dec 16, 2014 | Issued |
Array
(
[id] => 12527022
[patent_doc_number] => 10005850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers
[patent_app_type] => utility
[patent_app_number] => 15/103664
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35919
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/103664 | Use of poly alpha-1,3-glucan ethers as viscosity modifiers | Dec 14, 2014 | Issued |
Array
(
[id] => 10155818
[patent_doc_number] => 09187576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-17
[patent_title] => 'Deuterium-enriched hyaluronan'
[patent_app_type] => utility
[patent_app_number] => 14/552507
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8589
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14552507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/552507 | Deuterium-enriched hyaluronan | Nov 24, 2014 | Issued |
Array
(
[id] => 11844567
[patent_doc_number] => 09732109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Pesticidal compositions'
[patent_app_type] => utility
[patent_app_number] => 14/551335
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71530
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14551335
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/551335 | Pesticidal compositions | Nov 23, 2014 | Issued |
Array
(
[id] => 11357305
[patent_doc_number] => 09533948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Chemical compounds'
[patent_app_type] => utility
[patent_app_number] => 14/549034
[patent_app_country] => US
[patent_app_date] => 2014-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26361
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14549034
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/549034 | Chemical compounds | Nov 19, 2014 | Issued |
Array
(
[id] => 11099574
[patent_doc_number] => 20160296543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIES IN INFANTS FROM OR FED BY NON SECRETOR MOTHERS BY PROVIDING FUCOSYLATED-OLIGOSACCHARIDES IN PARTICULAR AMONG INFANTS AT RISK OR BORN BY C-SECTION'
[patent_app_type] => utility
[patent_app_number] => 15/036911
[patent_app_country] => US
[patent_app_date] => 2014-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10764
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036911 | Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section | Nov 3, 2014 | Issued |
Array
(
[id] => 11129232
[patent_doc_number] => 20160326207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'METHOD OF SUPPRESSING FORMATION OF PHOTOCROSSLINK, AND PHOTOREACTIVE NUCLEIC ACID IN WHICH AUTO-CROSSLINK FORMATION IS SUPPRESSED'
[patent_app_type] => utility
[patent_app_number] => 15/033422
[patent_app_country] => US
[patent_app_date] => 2014-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7500
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033422
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/033422 | Method of suppressing formation of photocrosslink, and photoreactive nucleic acid in which auto-crosslink formation is suppressed | Oct 29, 2014 | Issued |
Array
(
[id] => 10265898
[patent_doc_number] => 20150150895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'PHARMACEUTICAL ANTI-INFECTIVE COMPOSITION FOR INHALATION'
[patent_app_type] => utility
[patent_app_number] => 14/521000
[patent_app_country] => US
[patent_app_date] => 2014-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6816
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521000
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/521000 | PHARMACEUTICAL ANTI-INFECTIVE COMPOSITION FOR INHALATION | Oct 21, 2014 | Abandoned |
Array
(
[id] => 11348849
[patent_doc_number] => 20160367589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'MODULATION OF THE PHYSICAL INTERACTION BETWEEN PLATELETS AND THE CELL SURFACE EFFECTING CELL PROLIFERATION'
[patent_app_type] => utility
[patent_app_number] => 15/031020
[patent_app_country] => US
[patent_app_date] => 2014-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10252
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/031020 | Modulation of the physical interaction between platelets and the cell surface effecting cell proliferation | Oct 21, 2014 | Issued |
Array
(
[id] => 11248797
[patent_doc_number] => 09474273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Composition comprising an elicitor of the plant immune system'
[patent_app_type] => utility
[patent_app_number] => 14/511272
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20947
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511272
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511272 | Composition comprising an elicitor of the plant immune system | Oct 9, 2014 | Issued |